Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Shifamed LLC : Announces Completed Acquisition of Apama Medical

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/16/2017 | 01:04pm CEST

CAMPBELL, Calif., Oct. 16, 2017 /PRNewswire/ -- Shifamed LLC, a privately held medical device incubator, announced that Apama Medical, Inc., a Shifamed Portfolio Company, was acquired by Boston Scientific Corporation (NYSE: BSX) for $175 million in cash up-front and a maximum of $125 million in contingent payments over the period of 2018-2020, based on achievements of clinical and regulatory milestones.

Apama Medical has developed the Apama Radiofrequency (RF) Balloon Catheter System, a novel ablation catheter platform designed to combine the benefits of existing ablation technology, while incorporating additional unique features that address recognized unmet needs in the rapidly growing atrial fibrillation market. The Apama RF Balloon Catheter System is currently being evaluated in clinical studies and offers the potential to improve both procedural efficiency and control of the ablation therapy delivered.

"We are excited that Apama Medical is now part of the Boston Scientific pipeline of differentiated arrhythmia solutions," shared Amr Salahieh, Founder of Apama Medical and Founder & President of Shifamed LLC. "At the onset of the development of any Shifamed Portfolio Company, our goal is to create novel solutions that address unmet needs in the market."

Apama Medical is the third Shifamed Portfolio Company to be acquired since Shifamed's inception, preceded by Kalila Medical sold to Abbott in 2016 and Maya Medical sold to Covidien in 2012.

"Shifamed was formed out of my passion for engineering in the medical field and the ability to work alongside and enable others to develop innovative solutions that make a positive impact on patient lives," stated Salahieh. "We are thrilled to collaborate with companies like Boston Scientific that excel at bringing advanced solutions to the patients and care providers we serve."

About Shifamed
Founded in 2009 by serial entrepreneur Amr Salahieh, Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. To learn more about Shifamed, please visit www.shifamed.com.

MEDIA CONTACT:
Katie Arnold
SPRIG Consulting LLC
+1 (408) 805-0520
[email protected]

View original content:http://www.prnewswire.com/news-releases/shifamed-llc-announces-completed-acquisition-of-apama-medical-300536718.html

SOURCE Shifamed LLC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BOSTON SCIENTIFIC CORPORAT
10/16 SHIFAMED LLC : Announces Completed Acquisition of Apama Medical
10/13 BOSTON SCIENTIFIC : Navy Seeks Recording System Service Maintenance
10/12 BOSTON SCIENTIFIC : LSPRO Recording System Service Maint. Notice of Intent to So..
10/12 BOSTON SCIENTIFIC CORPORATION (NYSE : BSX) Files An 8-K Other Events
10/11 BOSTON SCIENTIFIC CORP : Other Events, Financial Statements and Exhibits (form 8..
10/11 BOSTON SCIENTIFIC : to acquire Apama Medical
10/09DJBOSTON SCIENTIFIC : Health-care Firms Used Radio, Social Media to Find Missing W..
10/09 MEDTRONIC : Med-tech firms scramble to restart production in Puerto Rico after H..
10/04 BOSTON SCIENTIFIC : agrees purchase of Apama Medical for up to $300mn
10/04 BOSTON SCIENTIFIC : Appoints Desiree Ralls-Morrison General Counsel and Corporat..
More news
News from SeekingAlpha
10/12 Wright Can't Get It Right
10/09 First meeting of new FDA advisory committee this week
10/06 YOUR DAILY PHARMA SCOOP : Gilead, Some History; Biogen's Spinraza, MDCO New Data..
10/02 Boston Scientific takes out Apama Medical for up to $300M
10/02 Right Time To Buy Medtronic? Know Why The Company Cannot Go Wrong In Cardiac ..
Financials ($)
Sales 2017 8 952 M
EBIT 2017 2 193 M
Net income 2017 1 176 M
Debt 2017 4 769 M
Yield 2017 -
P/E ratio 2017 37,07
P/E ratio 2018 28,25
EV / Sales 2017 5,08x
EV / Sales 2018 4,60x
Capitalization 40 738 M
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 31,0 $
Spread / Average Target 4,5%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian Meredith Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION36.48%40 738
THERMO FISHER SCIENTIFIC INC.34.10%77 329
DANAHER10.55%63 154
INTUITIVE SURGICAL67.64%41 191
ROYAL PHILIPS20.29%39 253
ILLUMINA60.25%30 705